Home-monitoring device helps to detect CNV earlier
FLORENCE, Italy — Home monitoring with a preferential hyperacuity perimetry device allows early detection of choroidal neovascularization-related changes in patients with early age-related macular degeneration.
“Early detection means better preservation of vision, better outcomes of therapy,” Anat Loewenstein, MD, PhD, said at the FLOREtina meeting.
“But in real life, patients find out they have AMD when they already have symptoms of metamorphopsia. Even when they enter studies, only a small percentage of patients have good functional vision,” Loewenstein said.
The ForeseeHome test (Notal Vision), based on preferential hyperacuity perimetry, allows early home-based detection of visual field distortions generated by CNV lesions. Patients with early-stage AMD are prescribed to perform the test at regular intervals, and their responses are automatically transmitted to a specialized monitoring center……
read more: http://www.healio.com/ophthalmology/retina-vitreous/news/online/%7B317c31c6-a2a4-47d0-b83d-215b0a43493c%7D/home-monitoring-device-helps-to-detect-cnv-earlier
About ForseeHome Device
Frequent monitoring with the ForeseeHome™ AMD Monitoring Program provides a safety net for monitoring changes in your vision between office visits, allowing your doctor to detect and diagnose wet AMD at its earliest stage.
Benefits of ForeseeHome
- Clinically proven to detect even the smallest changes in vision related to early signs of wet AMD
- Proactive monitoring of your vision from the comfort of home
- Peace of mind from knowing that your vision is being monitored between doctor visits
The earlier detection facilitated by ForeseeHome leads to earlier treatment of the disease and provides you with the best chance of protecting good, functional vision. http://www.foreseehome.com/